Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation GI2 2012

What is in the Pipeline for Coronary Artery Disease?

Presenter: Martin B. Leon

April 13, 2012

Presentation GI2 2012

The BioFreedom™ DES: Late Results, Technology Challenges, and Next Steps

Presenter: Eberhard Grube

April 13, 2012

Presentation GI2 2012

New Bifurcation (+ left main) Stent Designs and Clinical Results

Presenter: Martin B. Leon

April 13, 2012

Presentation GI2 2012

What Technology Modifications Required for Bioabsorbable Scaffolds to Broaden Indications for USE

Presenter: Ron Waksman

April 12, 2012

Presentation GI2 2012

The beginning of the stent era: the true story

Presenter: Patrick W. Serruys

April 12, 2012

Presentation GI2 2012

Pathology of DES with Biodegradable Polymer: Are They Really Better?

Presenter: Renu Virmani

April 12, 2012

Presentation GI2 2012

Drug-Eluting Balloon: Clinical Evidence for In-Stent Restenosis

Presenter: Marco V. Wainstein

April 12, 2012

Presentation GI2 2012

Bioabsorbable Scaffold: New and Evolving Designs

Presenter: Alexandre Abizaid

April 12, 2012

Presentation GI2 2012

10 Reasons Why the Metallic Drug-eluting Stent Should be Replaced by Bioresorbable Scaffold

Presenter: Patrick W. Serruys

April 12, 2012

Presentation GI2 2012

Why Do We Need Future Generation DES

Presenter: Martin B. Leon

April 11, 2012

Presentation GI2 2012

The Controversy: DES vs DEB for In-Stent Restenosis

Presenter: Pedro A. Lemos

April 11, 2012

Presentation GI2 2012

Focus on In-Stent Restenosis: Imaging to Guide the Best Treatment

Presenter: Jose Ribamar Costa

April 11, 2012

Advertisement

What is in the Pipeline for Coronary Artery Disease?

The BioFreedom™ DES: Late Results, Technology Challenges, and Next Steps

New Bifurcation (+ left main) Stent Designs and Clinical Results

What Technology Modifications Required for Bioabsorbable Scaffolds to Broaden Indications for USE

The beginning of the stent era: the true story

Pathology of DES with Biodegradable Polymer: Are They Really Better?

Drug-Eluting Balloon: Clinical Evidence for In-Stent Restenosis

Bioabsorbable Scaffold: New and Evolving Designs

10 Reasons Why the Metallic Drug-eluting Stent Should be Replaced by Bioresorbable Scaffold

Why Do We Need Future Generation DES

The Controversy: DES vs DEB for In-Stent Restenosis

Focus on In-Stent Restenosis: Imaging to Guide the Best Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content